This site is intended for U.S. healthcare professionals

Supporting Confidence During Angiographic Procedures

In angiography, Bayer prioritizes the operator experience by bringing intuitive design, ergonomic flexibility and technical expertise to support procedural confidence. Backed by on-site training, our approach helps you optimize your workflow from day one.

MEDRAD® Mark 7 Arterion Injection system on a mobile stand

MEDRAD® Mark 7 Arterion Injection System

Optimizes workflow control and maneuverability with ergonomic design and intuitive operation to support efficient angiography procedures in your busy cardiovascular suites.



MEDRAD® Mark V ProVis End of Life (EOL)

The MEDRAD® Mark V ProVis Injection System reached EOL in the US on December 31, 2025. Bayer is here to support your next steps, including upgrade pathways to the MEDRAD® Mark 7 Arterion Injection System.